Tuesday's #PreMarket Movers: Neuroderm, Microsoft, Medbox, Civeo And More
December 30, 2014 at 09:17 AM EST
Neuroderm Ltd (NASDAQ: NDRM) +30% - The company announced favorable Phase IIa Parkinson’s treatment study results. China ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.